Use of supportive palliative care lags for heart patients
While heart disease is the leading cause of death in the United States, relatively few of these patients receive a referral to palliative care, focusing on quality of life and value-based treatment
DCRI receives CRO Leadership Awards for fourth year
The DCRI was recognized in five categories, including Capabilities, Compatibility, Expertise, Phase IV, and Reliability.
DCRI helps FDA map strategy to broaden use of real-world evidence
Through projects such as ADAPTABLE, CTTI, and the NIH Collaboratory, the DCRI is defining how to use RWE in clinical research.
Organizations join forces to create global alliance against antibiotic resistance
The ARLG and COMBACTE will work together on a number of initiatives designed to fight drug-resistant infections.
ECHO program set to begin expansive child health research
The DCRI serves as the Coordinating Center for the program, which received single IRB approval to proceed with its expansive observational research.
Few people with heart failure take guideline-recommended drug
DCRI researchers found that heart failure patients are much more likely to take a guideline-recommended medication if they are started on the drug while still in the hospital.
Study finds lower death rates for TAVR centers that do more procedures
Hospitals that perform the highest volume of transcatheter-aortic valve replacement (TAVR) procedures have significantly lower mortality rates than centers that do fewer of the minimally invasive surgeries, according to an analysis by a collaboration that included the DCRI. The finding, published April 3 in the New England Journal of Medicine, comes as the Centers for Medicare & Medicaid Services is reconsidering the procedure’s coverage parameters, which established a center’s volume as a key criterion for reimbursement.
Lack of physician guidance, fear of side effects lead to lower statin adherence
Despite national guidelines indicating that statins can lower risk of heart attack and stroke, many patients who could benefit do not take them.
Large accountable care organizations committed to overhauled Medicare program
While most Accountable Care Organizations (ACOs) have committed to continue participating in the recently overhauled flagship Medicare Shared Savings Program (MSSP), physician-led ACOS are leaving at a higher rate than in 2017, new research from the Duke-Margolis Center for Health Policy and Leavitt Partners shows. Highlights of this research were published this month in Health Affairs. The DCRI’s Donald Taylor, PhD, is one of the study’s authors.
ACC 2019: 12-month results show ticagrelor safe in STEMI patients treated with thrombolysis
When comparing ischemic endpoints, no significant difference was found between patients who received ticagrelor and patients who received clopidogrel.